Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers

Affiliations

• ¹ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ² Children's Hospital of Philadelphia, Philadelphia, PA, USA.
• ³ Vanderbilt University Medical Center, Nashville, TN, USA.
• ⁴ Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
• ⁵ Section of Transplantation and Cellular Therapy, Children's Hospital Los Angeles, Los Angeles, CA, USA.
• ⁶ Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
• ⁷ Children's Hospital, University of Würzburg, Würzburg, Germany.
• ⁸ University of Michigan, Ann Arbor, MI, USA.
• ⁹ Mesoblast, Inc., New York, NY, USA.
• ¹⁰ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. [email protected].